To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Purpose

• To evaluate the efficacy of Biphenyl dimethyl dicarboxylate(DDB)/Garlic Oil in patients with elevated transaminase chronic liver disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: PharmaKing
• Treatments: 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester; Allyl sulfide; Silymarin

Criteria

Inclusion Criteria:

• Patients over 20years of age

• Patients with more 60 ALT in screening period.

• To evaluate ALT and AST at least three months.

• Serum Transaminase abnormal(before 6months), chronic liver disease or fatty liver, liver disease medical treatment at more than 30days

• Women of childbearing age get her consent for contraception, pregnancy urine test result negative.

Exclusion Criteria:

• ALT>10UNL on screening period.

• Current treatment on another clinical trial

• Pregnancy or breastfeeding